Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Endocyte Inc patents


Recent patent applications related to Endocyte Inc. Endocyte Inc is listed as an Agent/Assignee. Note: Endocyte Inc may have other listings under different names/spellings. We're not affiliated with Endocyte Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "E" | Endocyte Inc-related inventors


Vitamin receptor drug delivery conjugates for treating inflammation

Described herein are compositions, methods, compounds, conjugates, and kits for use in targeted drug delivery using drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations, such as inflammatory cells.. . ... Endocyte Inc

Drug delivery conjugates of tertiary amine containing drugs

The present disclosure relates to conjugates of tertiary amine containing drugs. The present disclosure also relates to pharmaceutical compositions of the conjugates described herein, methods of making, and methods of using the same.. ... Endocyte Inc

Methods of treating cancer with a psma ligand-tubulysin compound

The invention described herein pertains to drug delivery conjugates for targeted therapy. The invention described herein relates to methods of treating psma expressing cancers with a psma ligand-tubulysin compound. ... Endocyte Inc

Cancer imaging agent

The present disclosure relates to imaging agent formulations, methods for preparing imaging agent formulations and methods for using the same. The present disclosure also relates to kits for imaging agent formulations.. ... Endocyte Inc

Drug delivery conjugates containing unnatural amino acids and methods for using

Described herein are drug delivery conjugates for targeted therapy. In particular, described herein are drug delivery conjugates that include polyvalent linkers comprising one or more unnatural amino acids that are useful for treating cancers and inflammatory diseases.. ... Endocyte Inc

Tubulysin conjugate for use in treating cancer

The invention described herein pertains to drug delivery conjugates for targeted therapy. The invention described herein relates to methods of treating folate receptor-expressing cancers with a folate-tubulysin conjugate. ... Endocyte Inc

Binding ligand linked drug delivery conjugates of tubulysins

Described herein are compounds, pharmaceutical compositions and methods for treating pathogenic cell populations. The compounds described herein include conjugates of tubulysins and vitamin receptor binding ligands. ... Endocyte Inc

Bivalent linkers and conjugates thereof

Bivalent linkers to be included in or for preparing vitamin, drug, diagnostic agent, and/or imaging agent conjugates are described.. . ... Endocyte Inc

Methods of treating cancer with tubulysin conjugates

The invention described herein pertains to drug delivery conjugates for targeted therapy. The invention described herein relates to methods of treating folate receptor-expressing cancers with a folate-tubulysin conjugate. ... Endocyte Inc

Conjugates for treating diseases caused by psma expressing cells

The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by psma expressing cells, such as prostate cancer cells, using compounds capable of targeting psma expressing cells.. ... Endocyte Inc

Folate receptor binding conjugates of antifolates

Conjugates of antifolates, releasable linkers, and drugs, and pharmaceutical compositions containing them are described. The conjugates are useful for treating diseases arising from pathogenic cell populations. ... Endocyte Inc

Conjugates containing hydrophilic spacer linkers

Described herein are compositions and methods for use in targeted drug delivery using cell receptor binding drug delivery conjugates containing hydrophilic spacer linkers for use in imaging, diagnosing, and/or treating diseases and disease states caused by pathogenic cell populations.. . ... Endocyte Inc

Drug delivery conjugates for treating resistant cancer and for use in combination therapy

Described herein are drug delivery conjugates for targeted therapy. In particular, described herein are drug delivery conjugates that include polyvalent linkers comprising one or more unnatural amino acids that are useful for treating cancers and inflammatory diseases. ... Endocyte Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Endocyte Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Endocyte Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###